Friedrich-Carl von Rundstedt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Friedrich-Carl von Rundstedt has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Alexander Roosen
Helios Klinikum Velbert, Velbert, Deutschland
1 shared publication- C. Wach
Universitätsklinikum Wuppertal, Wuppertal, Germany
1 shared publication Chris Protzel
Helios Klinikum Schwerin, Schwerin, Deutschland
1 shared publication- Christian P. Meyer
Universitätsklinik für Urologie, Ruhr-Universität Bochum, Klinikum Herford, Herford, Deutschland
1 shared publication Christine Lenhart
Fakultät für Gesundheit, Private Universität Witten/Herdecke, Witten/Herdecke, Deutschland
1 shared publication- Christine Walles
Department of Pathology and Molecular Pathology, Helios University Hospital Wuppertal, 42283 Wuppertal, Germany
1 shared publication
Latest Publications
- Open Access
- 16 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (24) , 8906
Prostate Artery Embolization vs. Holmium Laser Enucleation of the Prostate: A Matched Pair Analysis of Functional Outcomes and Complications
Background: This retrospective matched-pair analysis compared functional outcomes and complications of prostate artery embolization (PAE) using 250 µm microparticles and holmium laser enucleation of the prostate (HoLEP) in patients with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). Methods: A total of 69 PAE patients were matched 1:1 to 69 HoLEP patients using propensity scores based on age, prostate volume (PV), and IPSS. Follow-up was standardized at six months for the PAE cohort, while HoLEP outcomes were assessed cross-sectionally (median 52.9 months). All comparisons were therefore interpreted as cross-sectional analyses rather than time-matched outcomes. Secondary endpoints were complications according to the Clavien–Dindo Classification. Results: At baseline, there were no significant differences between PAE and HoLEP regarding IPSS, QoL, or Qmax. Both interventions led to significant within-group improvements in IPSS, QoL, and Qmax (p < 0.001). Between-group comparisons demonstrated significantly greater improvement in IPSS, Qmax, and QoL following HoLEP (all p < 0.05). Erectile function remained stable after PAE and showed a non-significant decrease after HoLEP. Severe complications (Clavien–Dindo ≥ Grade III) were not observed after PAE. These findings should be interpreted considering the study’s main limitations, including the small cohort size, its retrospective matched-pair design, and variability in surgeons’ HoLEP experience. Conclusions: PAE with 250 µm microparticles and HoLEP are both effective and safe procedures. While PAE compared to HoLEP is less effective regarding functional outcome, it showed no difference in QoL improvement and is associated with no greater grade II complications.
- 16 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (24) , 8906
Open AccessProstate Artery Embolization vs. Holmium Laser Enucleation of the Prostate: A Matched Pair Analysis of Functional Outcomes and Complications
Background: This retrospective matched-pair analysis compared functional outcomes and complications of prostate artery embolization (PAE) using 250 µm microparticles and holmium laser enucleation of the prostate (HoLEP) in patients with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). Methods: A total of 69 PAE patients were matched 1:1 to 69 HoLEP patients using propensity scores based on age, prostate volume (PV), and IPSS. Follow-up was standardized at six months for the PAE cohort, while HoLEP outcomes were assessed cross-sectionally (median 52.9 months). All comparisons were therefore interpreted as cross-sectional analyses rather than time-matched outcomes. Secondary endpoints were complications according to the Clavien–Dindo Classification. Results: At baseline, there were no significant differences between PAE and HoLEP regarding IPSS, QoL, or Qmax. Both interventions led to significant within-group improvements in IPSS, QoL, and Qmax (p < 0.001). Between-group comparisons demonstrated significantly greater improvement in IPSS, Qmax, and QoL following HoLEP (all p < 0.05). Erectile function remained stable after PAE and showed a non-significant decrease after HoLEP. Severe complications (Clavien–Dindo ≥ Grade III) were not observed after PAE. These findings should be interpreted considering the study’s main limitations, including the small cohort size, its retrospective matched-pair design, and variability in surgeons’ HoLEP experience. Conclusions: PAE with 250 µm microparticles and HoLEP are both effective and safe procedures. While PAE compared to HoLEP is less effective regarding functional outcome, it showed no difference in QoL improvement and is associated with no greater grade II complications.
- Open Access
- 9 October 2025
- Published by Springer Nature in Die Urologie
- Vol. 65 (3) , 288-297
Selbstkritische, multizentrische Analyse der Behandlungs- und Kodierqualität am Beispiel der Nephroureterektomie anhand von Abrechnungsdaten
Zusammenfassung: Hintergrund: Urothelkarzinome des oberen Harntrakts (UTUC) sind selten und machen etwa 5–10 % aller urothelialen Karzinome aus. Im Gegensatz zu Urothelkarzinomen der Harnblase sind UTUC bei Diagnosestellung oft bereits invasiv. Die radikale Nephroureterektomie (RNU) ist der Standard für die Behandlung, wobei minimalinvasive Verfahren zunehmend an Bedeutung gewinnen. Ziel dieser Studie war es, die Entwicklung der RNU in Hinblick auf Fallzahl, Operationsmethode, Behandlungsqualität und Leitlinienadhärenz herauszuarbeiten. Material und Methoden: Die Studie basiert auf einer retrospektiven Analyse von G‑DRG-Abrechnungsdaten aus 87 Helios-Krankenhäusern in Deutschland für den Zeitraum 2016 bis 2022. Eingeschlossen wurden Patienten mit einer Hauptdiagnose UTUC, die sich einer RNU unterzogen hatten. Die Operationsverfahren wurden in offen-chirurgisch und minimalinvasiv (laparoskopisch oder roboterassistiert) unterteilt. Es wurden verschiedene Parameter wie Krankenhausverweildauer (KVD), Komplikationen und postoperative Maßnahmen analysiert. Eine Post-hoc-Umfrage der Kliniken diente der Validierung der Abrechnungsdaten. Ergebnisse: Insgesamt wurden 594 Patienten mit RNU behandelt. Der Anteil roboterassistierter RNU stieg kontinuierlich an, während die offen-chirurgischen Eingriffe abnahmen. Minimalinvasive Verfahren führten zu kürzeren Krankenhausaufenthalten (9,9 vs. 12,3 Tage; p < 0,001), weniger Komplikationen wie Blutungsanämien (12 % vs. 26 %; p < 0,001) und intensivmedizinischer Betreuung (57 % vs. 71 %; p < 0,001). Die Resektion der Blasenmanschette wurde seltener bei der minimalinvasiven RNU in der Kodierung erfasst (6,6 % vs. 46 %; p < 0,001). Die intravesikale Rezidivprophylaxe wurde unabhängig von der Operationsmethode nur bei einem geringen Anteil der Patienten kodiert (10 % vs. 6,9 %; p = 0,116), wobei die Post-hoc-Umfrage zeigte, dass die Blasenmanschettenresektion von 92 % und postoperative Instillation von 52 % der Helios-Kliniken durchgeführt werden. Schlussfolgerung: Roboterassistierte Operationen zeigten Vorteile hinsichtlich kürzerer Krankenhausaufenthalte und geringerer Komplikationsraten. Allerdings wurde eine unzureichende und verbesserungswürdige Leitlinienadhärenz bei der postoperativen Instillation festgestellt. Die Analyse zeigt eine deutliche Diskrepanz („real world evidence gap“) zwischen kodierten DRG-Daten und tatsächlicher klinischer Versorgung. Dieses Missverhältnis beeinflusst zentrale Struktur- und Leistungsentscheidungen im deutschen Gesundheitssystem und muss bei der Interpretation administrativer Datensätze dringend berücksichtigt werden. Graphic
- 9 October 2025
- Published by Springer Nature in Die Urologie
- Vol. 65 (3) , 288-297
Open AccessSelbstkritische, multizentrische Analyse der Behandlungs- und Kodierqualität am Beispiel der Nephroureterektomie anhand von Abrechnungsdaten
Zusammenfassung: Hintergrund: Urothelkarzinome des oberen Harntrakts (UTUC) sind selten und machen etwa 5–10 % aller urothelialen Karzinome aus. Im Gegensatz zu Urothelkarzinomen der Harnblase sind UTUC bei Diagnosestellung oft bereits invasiv. Die radikale Nephroureterektomie (RNU) ist der Standard für die Behandlung, wobei minimalinvasive Verfahren zunehmend an Bedeutung gewinnen. Ziel dieser Studie war es, die Entwicklung der RNU in Hinblick auf Fallzahl, Operationsmethode, Behandlungsqualität und Leitlinienadhärenz herauszuarbeiten. Material und Methoden: Die Studie basiert auf einer retrospektiven Analyse von G‑DRG-Abrechnungsdaten aus 87 Helios-Krankenhäusern in Deutschland für den Zeitraum 2016 bis 2022. Eingeschlossen wurden Patienten mit einer Hauptdiagnose UTUC, die sich einer RNU unterzogen hatten. Die Operationsverfahren wurden in offen-chirurgisch und minimalinvasiv (laparoskopisch oder roboterassistiert) unterteilt. Es wurden verschiedene Parameter wie Krankenhausverweildauer (KVD), Komplikationen und postoperative Maßnahmen analysiert. Eine Post-hoc-Umfrage der Kliniken diente der Validierung der Abrechnungsdaten. Ergebnisse: Insgesamt wurden 594 Patienten mit RNU behandelt. Der Anteil roboterassistierter RNU stieg kontinuierlich an, während die offen-chirurgischen Eingriffe abnahmen. Minimalinvasive Verfahren führten zu kürzeren Krankenhausaufenthalten (9,9 vs. 12,3 Tage; p < 0,001), weniger Komplikationen wie Blutungsanämien (12 % vs. 26 %; p < 0,001) und intensivmedizinischer Betreuung (57 % vs. 71 %; p < 0,001). Die Resektion der Blasenmanschette wurde seltener bei der minimalinvasiven RNU in der Kodierung erfasst (6,6 % vs. 46 %; p < 0,001). Die intravesikale Rezidivprophylaxe wurde unabhängig von der Operationsmethode nur bei einem geringen Anteil der Patienten kodiert (10 % vs. 6,9 %; p = 0,116), wobei die Post-hoc-Umfrage zeigte, dass die Blasenmanschettenresektion von 92 % und postoperative Instillation von 52 % der Helios-Kliniken durchgeführt werden. Schlussfolgerung: Roboterassistierte Operationen zeigten Vorteile hinsichtlich kürzerer Krankenhausaufenthalte und geringerer Komplikationsraten. Allerdings wurde eine unzureichende und verbesserungswürdige Leitlinienadhärenz bei der postoperativen Instillation festgestellt. Die Analyse zeigt eine deutliche Diskrepanz („real world evidence gap“) zwischen kodierten DRG-Daten und tatsächlicher klinischer Versorgung. Dieses Missverhältnis beeinflusst zentrale Struktur- und Leistungsentscheidungen im deutschen Gesundheitssystem und muss bei der Interpretation administrativer Datensätze dringend berücksichtigt werden. Graphic
- Open Access
- 16 June 2025
- Published by Elsevier in Urology Case Reports
- Vol. 61, 103105
Fibroblast-directed PET imaging reveals a case of retroperitoneal fibrosis after immunotherapy for metastatic urothelial cancer of the upper tract
- 16 June 2025
- Published by Elsevier in Urology Case Reports
- Vol. 61, 103105
Open AccessFibroblast-directed PET imaging reveals a case of retroperitoneal fibrosis after immunotherapy for metastatic urothelial cancer of the upper tract
- Open Access
Degenerative Changes in Aging Human Pelvic Lymph Nodes—A Reason to Rethink Staging and Therapy of Regional Malignancies?
Lymph node metastases are common in pelvic urological tumors, and the age-related remodeling process of the pelvic lymph nodes influences metastatic behavior. The aim of this work is to characterize age-related degenerative changes in the pelvic lymph nodes with respect to their occurrence and extent. A total of 5173 pelvic lymph nodes of 390 patients aged 44 to 79 years (median 68 years, IQR 62–71 years) were histologically examined for degenerative structural changes. Lymph node size, lipomatous atrophy, capsular fibrosis, framework fibrosis, and calcifications were recorded semi-quantitatively and evaluated by age group. Significantly more lymph nodes p = 0.001). The incidence of framework fibrosis, capsular fibrosis, and calcifications increased significantly with increasing patient age (p < 0.001). In lipomatous atrophy, an increase in mild to moderate lipomatous atrophy was observed with increasing age (p < 0.001). In this, the largest study to date on this topic, age-related degenerative changes in pelvic lymph nodes were proven. Due to the consecutive decrease in hte filtration function of pelvic lymph nodes with increasing age, staging and therapy of metastatic pelvic urologic carcinomas should be reconsidered.
Open AccessDegenerative Changes in Aging Human Pelvic Lymph Nodes—A Reason to Rethink Staging and Therapy of Regional Malignancies?
Lymph node metastases are common in pelvic urological tumors, and the age-related remodeling process of the pelvic lymph nodes influences metastatic behavior. The aim of this work is to characterize age-related degenerative changes in the pelvic lymph nodes with respect to their occurrence and extent. A total of 5173 pelvic lymph nodes of 390 patients aged 44 to 79 years (median 68 years, IQR 62–71 years) were histologically examined for degenerative structural changes. Lymph node size, lipomatous atrophy, capsular fibrosis, framework fibrosis, and calcifications were recorded semi-quantitatively and evaluated by age group. Significantly more lymph nodes p = 0.001). The incidence of framework fibrosis, capsular fibrosis, and calcifications increased significantly with increasing patient age (p < 0.001). In lipomatous atrophy, an increase in mild to moderate lipomatous atrophy was observed with increasing age (p < 0.001). In this, the largest study to date on this topic, age-related degenerative changes in pelvic lymph nodes were proven. Due to the consecutive decrease in hte filtration function of pelvic lymph nodes with increasing age, staging and therapy of metastatic pelvic urologic carcinomas should be reconsidered.
- Open Access
- 17 December 2021
- Published by Springer Nature in BMC Urology
- Vol. 21 (1) , 1-4
Intravesical ichthyosis: a rare case report
Background: Ichthyosis is a rare skin disorder, in which the shedding of squamous cells is altered. Intravesical ichthyosis is an extremely rare condition. There is evidence for an association with intravesical condylomata accuminata, caused by urogenital infections of the human papilloma virus. These lesions are generally benign but known to be of a carcinogenic potential and therefore should be treated immediately and followed-up closely. Case presentation: We present the case of a 39-year-old woman who presented with recurrent urinary tract infections. During cystoscopy diffuse black pigmented flat bladder tumours were visualized. After transurethral resection the pathological report diagnosed an ichthyosis vesicae. Conclusion: We recommend a complete resection with frequent clinical and cystoscopic follow-up. Furthermore, testing for the human papilloma virus should be performed and a vaccination should be offered to the patient. As ichthyosis vesicae is a rare phenomenon, there is an evident lack of clinical data regarding therapy, prognosis and follow-up. With our report, we want to emphasize the need for further research.
- 17 December 2021
- Published by Springer Nature in BMC Urology
- Vol. 21 (1) , 1-4
Open AccessIntravesical ichthyosis: a rare case report
Background: Ichthyosis is a rare skin disorder, in which the shedding of squamous cells is altered. Intravesical ichthyosis is an extremely rare condition. There is evidence for an association with intravesical condylomata accuminata, caused by urogenital infections of the human papilloma virus. These lesions are generally benign but known to be of a carcinogenic potential and therefore should be treated immediately and followed-up closely. Case presentation: We present the case of a 39-year-old woman who presented with recurrent urinary tract infections. During cystoscopy diffuse black pigmented flat bladder tumours were visualized. After transurethral resection the pathological report diagnosed an ichthyosis vesicae. Conclusion: We recommend a complete resection with frequent clinical and cystoscopic follow-up. Furthermore, testing for the human papilloma virus should be performed and a vaccination should be offered to the patient. As ichthyosis vesicae is a rare phenomenon, there is an evident lack of clinical data regarding therapy, prognosis and follow-up. With our report, we want to emphasize the need for further research.